Mali: Diabetes prevalence

* indicates monthly or quarterly data series
 Mali

Diabetes prevalence, percent of population ages 20-79

 Latest value 2.10
 Year 2021
 Measure percent
 Data availability 2011 - 2021
 Average 2.00
 Min - Max 1.90 - 2.10
 Source International Diabetes Federation
The latest value from 2021 is 2.1 percent, an increase from 1.9 percent in 2011. In comparison, the world average is 8.60 percent, based on data from 195 countries. Historically, the average for Mali from 2011 to 2021 is 2 percent. The minimum value, 1.9 percent, was reached in 2011 while the maximum of 2.1 percent was recorded in 2021. See the global rankings for that indicator or use the country comparator to compare trends over time.
Select indicator
* indicates monthly or quarterly data series


Recent data
Mali - Diabetes prevalence - Recent values chart




Definition: Diabetes prevalence refers to the percentage of people ages 20-79 who have type 1 or type 2 diabetes. It is calculated by adjusting to a standard population age-structure.

Selected articles from our guide:

What factors determine the exchange rates

International lending and sovereign debt

All articles



 Related indicators Latest Reference Measure
 Health spending per capita 35.45 2020 U.S. dollars
 Health spending as percent of GDP 4.31 2020 percent
 Life expectancy 59.42 2022 years
 Life expectancy, female 60.83 2022 years
 Life expectancy, male 58.07 2022 years
 Birth rate 41.64 2021 births per 1000 people
 Death rate 8.95 2022 deaths per 1000 people
 Fertility rate 5.87 2022 births per woman
 HIV infections 0.90 2022 percent
 Tuberculosis 49.00 2022 cases per 100,000 people
 Diabetes prevalence 2.10 2021 percent
 Prevalence of anemia among children 79.00 2019 percent
 Prevalence of undernourishment 12.80 2021 percent
 Suicides 4.10 2019 suicides per 100,000 people
 DPT immunization rate 77 2022 percent
 Hepatitis B immunization rate 77 2022 percent
 Measles immunization rate 70 2022 percent
 Traffic accident deaths 22.70 2019 deaths per 100,000 people
This site uses cookies.
Learn more here


OK